Literature DB >> 35835900

The role of MBL, PCT, CRP, neutrophil-lymphocyte ratio, and platelet lymphocyte ratio in differentiating infections from flares in lupus.

Balaji Musunuri1,2, Rina Tripathy3, Sunali Padhi4, Aditya K Panda5, Bidyut K Das6.   

Abstract

BACKGROUND: The distinction between infection and flare in systemic lupus erythematosus (SLE) has always been a dilemma for clinicians as the clinical and biochemical profiles overlap. The present study evaluated affordable biomarkers to distinguish infection from flare in an SLE cohort in a tertiary care center in eastern India.
METHODS: One hundred and fifty-two SLE patients were clinically evaluated and enrolled in the present study. Hematological, immunological, and biochemical profiles and various biomarkers such as C reactive protein (CRP), procalcitonin (PCT), and Mannose-binding lectin (MBL) were quantified.
RESULTS: One hundred and fifty-two patients (152) were enrolled in the present study and all had SLEDAI scores of more than 4. From which 70 had infection, and the common infections were urinary tract infection (34.28%) followed by pneumonia (27.14%). Neutrophil-lymphocyte ratio (NLR) and C-reactive protein (CRP) were significantly elevated in SLE with infections (NLR: 5.84 ± 2.47; CRP: 30.56 ± 41.63) than those with flare (NLR: 3.87 ± 2.62; CRP: 8.73 ± 9.53). The receiver operating characteristic curve (ROC) analysis revealed CRP, PLR, and NLR as important markers for predicting infections (CRP: AUC = 0.682, p = 0.0001; PLR: AUC = 0.668, p = 0.0008; NLR: AUC = 0.742, p < 0.0001). The MBL and PCT levels were comparable among SLE flare and those with infections.
CONCLUSIONS: NLR and CRP levels are affordable biomarkers to distinguish infections from flares in SLE. MBL and PCT could not differentiate flare from an infection. Key Points • Biomarkers for the differentiation of infection and flare in SLE are limited. • NLR, PLR, and CRP are promising biomarkers to enable differentiation. • PCT and MBL are not ideal biomarkers to differentiate infection from flare.
© 2022. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).

Entities:  

Keywords:  Biomarkers; C reactive protein; Flare; Infection; Mannose-binding lectin; Neutrophil–lymphocyte ratio; PCT; Systemic lupus erythematosus

Mesh:

Substances:

Year:  2022        PMID: 35835900     DOI: 10.1007/s10067-022-06285-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  31 in total

Review 1.  The epidemiology of systemic lupus erythematosus.

Authors:  M Siegel; S L Lee
Journal:  Semin Arthritis Rheum       Date:  1973       Impact factor: 5.532

Review 2.  Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden.

Authors:  N Danchenko; J A Satia; M S Anthony
Journal:  Lupus       Date:  2006       Impact factor: 2.911

3.  C-reactive protein is a more sensitive and specific marker for diagnosing bacterial infections in systemic lupus erythematosus compared to S100A8/A9 and procalcitonin.

Authors:  Hyoun-Ah Kim; Ja-Young Jeon; Jeong-Mi An; Bo-Ram Koh; Chang-Hee Suh
Journal:  J Rheumatol       Date:  2012-02-15       Impact factor: 4.666

4.  Racial/Ethnic variation in all-cause mortality among United States medicaid recipients with systemic lupus erythematosus: a Hispanic and asian paradox.

Authors:  José A Gómez-Puerta; Medha Barbhaiya; Hongshu Guan; Candace H Feldman; Graciela S Alarcón; Karen H Costenbader
Journal:  Arthritis Rheumatol       Date:  2015-03       Impact factor: 10.995

5.  High-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus.

Authors:  N Firooz; D A Albert; D J Wallace; M Ishimori; D Berel; M H Weisman
Journal:  Lupus       Date:  2011-03-24       Impact factor: 2.911

6.  Incidence of systemic lupus erythematosus in Finland, 2000-2007, a nationwide study.

Authors:  Pia Elfving; Kari Puolakka; Hannu Kautiainen; Lauri J Virta; Timo Pohjolainen; Oili Kaipiainen-Seppänen
Journal:  Clin Exp Rheumatol       Date:  2014-10-20       Impact factor: 4.473

7.  Hospitalization of individuals with systemic lupus erythematosus: characteristics and predictors of outcome.

Authors:  C J Edwards; T Y Lian; H Badsha; C L Teh; N Arden; H H Chng
Journal:  Lupus       Date:  2003       Impact factor: 2.911

Review 8.  Impact of race and ethnicity in the course and outcome of systemic lupus erythematosus.

Authors:  Luis Alonso González; Sergio M A Toloza; Graciela S Alarcón
Journal:  Rheum Dis Clin North Am       Date:  2014-06-07       Impact factor: 2.670

Review 9.  Infection and disease activity in systemic lupus erythematosus: a review of hospitalized patients.

Authors:  K N Duffy; C M Duffy; D D Gladman
Journal:  J Rheumatol       Date:  1991-08       Impact factor: 4.666

Review 10.  The geoepidemiology of systemic lupus erythematosus.

Authors:  Andrea T Borchers; Stanley M Naguwa; Yehuda Shoenfeld; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2009-12-24       Impact factor: 9.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.